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During human placentation, mononuclear cytotrophoblasts fuse to form multinucleated
syncytia ensuring hormonal production and nutrient exchanges between the maternal
and fetal circulation. Syncytial formation is essential for the maintenance of pregnancy
and for fetal growth. The cAMP signaling pathway is the major route to trigger
trophoblast fusion and its activation results in phosphorylation of specific intracellular
target proteins, in transcription of fusogenic genes and assembly of macromolecular
protein complexes constituting the fusogenic machinery at the plasma membrane.
Specificity in cAMP signaling is ensured by generation of localized pools of cAMP
controlled by cAMP phosphodiesterases (PDEs) and by discrete spatial and temporal
activation of protein kinase A (PKA) in supramolecular signaling clusters inside the
cell organized by A-kinase-anchoring proteins (AKAPs) and by organization of signal
termination by protein phosphatases (PPs). Here we present original observations on the
available components of the cAMP signaling pathway in the human placenta including
PKA, PDE, and PP isoforms as well as AKAPs. We continue to discuss the current
knowledge of the spatiotemporal regulation of cAMP signaling triggering trophoblast
fusion.
Keywords: protein kinase A, cAMP, AKAPs, phosphodiesterases, phosphatases, placenta, trophoblast fusion
Introduction
Cell fusion processes are essential for fertilization, fetal and placental development, skeletal muscle
formation, bone homeostasis and appears to play a role in metastasis (Midgley et al., 1963;
Zambonin Zallone et al., 1984; Wakelam, 1985; Oren-Suissa and Podbilewicz, 2007; Lu and Kang,
2009). Cell fusion and syncytia formation involve the mixing of plasma membrane components
and cell contents between two or more cells. Although occurring in a variety of biological contexts,
diﬀerent fusion processes share many of the same steps that are tightly regulated in space and time
(Pérot et al., 2011).
Human embryo implantation requires placentation, a process in which fetal cytotrophoblasts
(CT) invade the maternal endometrium to form an interphase with the maternal circulation,
ensuring eﬀective exchange of gases, nutrients, and the secretion of pregnancy-speciﬁc hormones
Frontiers in Pharmacology | www.frontiersin.org 1 September 2015 | Volume 6 | Article 202
Gerbaud et al. cAMP signaling in cell fusion
(i.e., hCG: human chorionic gonadotropin and hPL: human
placental lactogen) (Eaton and Contractor, 1993; Ogren and
Talamentes, 1994; Benirschke and Kaufmann, 2000). Throughout
pregnancy CTs fuse to form a multinucleated syncytia on
chorionic villi extending into the maternal placental blood
circulation. Due to their capacity to diﬀerentiate into syncytia
allowing essential placental exchange between mother and
child necessary for fetal growth, the CT plays an essential
role during human pregnancy. The in vivo fusion process in
the placenta is reproducible in vitro using puriﬁed human
CTs, which aggregate and then fuse to form non-proliferative,
multinucleated, endocrine active syncytiotrophoblasts (STs;
Figure 1; Kliman et al., 1986). Numerous proteins have been
reported to be implicated in cell fusion processes such as
tight junction, adherens junction, and gap junction proteins
(Coutifaris et al., 1991; Dahl et al., 1995; Mbalaviele et al., 1995;
Ilvesaro et al., 2000; Frendo et al., 2003; Charrasse et al., 2007;
Pidoux et al., 2010).
The cAMP signaling pathway is known to play a critical role in
induction of CT and myoblast cell fusion reviewed in (Gerbaud
and Pidoux, 2015). For instance, in human placentation, hCG
stimulates cytrophoblast fusion in an autocrine or paracrine
fashion through binding to the LH/CG receptor (LH/CG-R),
activating a speciﬁc adenylyl cyclase (AC) and the synthesis
of intracellular cAMP as second messenger (Figure 2). The
nine transmembrane AC isoforms have been identiﬁed with
various expression levels in human CT and on the plasma
and microvillous membrane of the ST (Sato and Ryan, 1971;
Matsubara et al., 1987; Bernatchez et al., 2003).
Next, the cAMP increase leads to activation of down-
stream eﬀectors such as cAMP-dependent protein kinase A
(PKA) and the phosphorylation of speciﬁc targets (Tasken
and Aandahl, 2004). Whereas, PKA is known to be the
main cAMP eﬀector, other intracellular eﬀectors exist such as
exchange proteins activated by cAMP (Epac) and the cyclic
nucleotide-gated ion channels (Walsh et al., 1968; Nakamura
and Gold, 1987; de Rooij et al., 1998; Kawasaki et al., 1998)
(Figure 2). The cAMP signaling pathway is one of the
best-characterized signal transduction pathways and requires
a high level of spatial and temporal regulation to convey
the appropriate inputs. The temporal regulation is achieve by
the cAMP synthesis through AC and metabolized by cAMP-
phosphodiesterase (PDE) activity. Both AC and PDE establish
in cAMP microdomains within the cell (Zaccolo and Pozzan,
2002). Furthermore, A-kinase anchoring proteins (AKAPs)
provide through PKA anchoring a spatial regulation of the
cAMP/PKA signaling by placing the kinase in the vicinity
substrates.
Little is known about AKAP proteins underlying the spatio-
temporal regulation of the cAMP-induced human cytrophoblast
fusion and regulation of endocrine functions in the placenta.
However, we have examined the functional role of AKAP-
anchored signaling complexes human primary CTs in a recent
report (Pidoux et al., 2014). Here we provide for the ﬁrst time
original data and on the repertoire of cAMP signal components
in the human placenta and compile the current knowledge about
the role of the AKAP proteins underlying cell fusion process.
Materials and Methods
Cell Culture
Villous CTs were isolated from term placentas and cultured
as described previously (Pidoux et al., 2014). BeWo cells were
obtained from American Type Culture Collection (Manassas, VA,
USA) and cultured as described by manufacturer.
Immunolocalization Studies
Immunocytoﬂuorescence was performed as described previously
(Pidoux et al., 2014).
Fusion Assay
Cell fusion was quantiﬁed by trophoblast fusion assays as
described previously (Pidoux et al., 2014). Brieﬂy, fusion indices
were calculated as the ratio of the number of nuclei in STs divided
by the number of total nuclei. A ST was deﬁned as at least
FIGURE 1 | Model of cultured villous trophobasts purified from human placenta. (Left) Schematic view of human chorionic villi. VCT for villous
cytotrophoblast, ST for syncytiotrophoblast, and EVT for extravillous trophoblast. (Right, upper) Model of trophoblast fusion. Cytotrophoblasts (CT) aggregate after
24 to 48 h of culture, and fuse into a ST after 72 h, which secretes human chorionic gonadotropin (hCG) and human placental lactogen (hPL). (Right, Lower) Human
trophoblast stained at 24 and 72 h of culture for desmoplakin (magenta) and nuclei (DAPI, cyan). Scale bar: 15 μm.
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FIGURE 2 | Schematic depiction of hCG/cAMP signaling pathway in
trophoblasts. Ligand (hCG) binding to the LH/CG-R receptor (LH/CG-R), a G
protein-coupled receptor (GPCR), activates adenylyl cyclase (AC) in its
proximity and generates pools of cAMP. The local concentration and
distribution of the cAMP gradient is limited by phosphodiesterases (PDEs),
that hydrolyse cAMP to 5′-AMP. Subcellular structures may harbor specific
isozymes of protein kinase A (PKA) that, through anchoring to
A-kinase-anchoring proteins (AKAPs), are localized in the vicinity of the
receptor and the cyclase. PDEs are also anchored and serve to limit the
extension and duration of cAMP gradients. These mechanisms serve to
localize and limit the assembly and triggering of specific pathways to a defined
area of the cell close to the substrate. Cyclic AMP has effects on a range of
effector molecules encompassing PKA, PDEs, Epacs (exchange proteins
activated by cAMP) and cyclic nucleotide-gated ion channels (CNGs).
three nuclei surrounded by a cell membrane as identiﬁed by
discontinuous desmoplakin immunostaining.
Protein Sample Preparation and Immunoblot
Analysis
Cell extracts were prepared as described previously (Pidoux
et al., 2014). Protein samples were resolved by SDS-PAGE
and immunoblotted with antibodies (catalog numbers and
supplier are indicated unless stated above) against PKA RIα
(0.25 μg/ml; 4D7; BD Biosciences), PKA RIIα (0.25 μg/ml;
612243; BD Biosciences), PKA RIIβ (0.25 μg/ml; 610626; BD
Biosciences); PKA Cα/β (0.25 μg/ml; 610980; BD Biosciences);
AKAP18 (0.5 μg/ml; WH0009465M1; Sigma–Aldrich); GAPDH
(1 μg/ml; G8795; Sigma–Aldrich). After incubation with the
appropriate HRP-conjugated secondary antibody, blots were
developed by using Supersignal West Pico substrate (Thermo
Scientiﬁc, Illkirch, France).
R-Overlays
R-overlays were performed as described previously (Hausken
et al., 1998) by using 32P-labeled recombinant murine RIIα.
Membranes with immobilized proteins were blocked in Blotto
(5% (w/v) non-fat dry milk plus 0.1% BSA in TBS). Puriﬁed
recombinant R (4 μg) was radiolabeled with puriﬁed catalytic
subunit (C) (0.02 μg/μl) and [γ-32P]ATP (1.4 μCi/μl) in a buﬀer
containing 50 mM MOPS pH 6.8 with 50 mM NaCl, 2 mM
MgCl2, and 1 mM DTT, and separated from free 32P-ATP by
gel ﬁltration in G-50 sepharose. Membranes were incubated with
1 × 106 cpm/ml of 32P-labeled recombinant R in TBS-T. For
competition assays, Ht31 peptide was added to the radiolabeled
R at a concentration of 500 nM and incubated for 2 h before the
membranes were added. The membranes were washed in TBS-T
and subjected to autoradiography.
Peptide Synthesis and Loading
Peptides used in trophoblast fusion assay (PKI:
R9-TYADFIASGRTGRRNAI and scrambled PKI: R11-
ANITSGYFDTIAAGR) were synthesized on an Intavis MultiPep
robot (Intavis Bioanalytical Instruments AG), uncoupled and
veriﬁed by high performance liquid chromatography (HPLC).
The concentrations of the peptides were determined by amino
acid analysis using an amino acid analyzer from Thermo
Scientiﬁc Dionex. PKI peptide and its respective control were
used at 10 μM.
Pull-Down Assays
cAMP pulldown assays (8-AHA-cAMP-agarose beads) were
performed as described previously (Pidoux et al., 2014). The
lysate-bead suspensions were subjected to LC-MS/MS.
Protein Identification by LC–MS/MS
Protein identiﬁcations were performed as described previously
(Pidoux et al., 2014).
siRNA and Mammalian Expression Vector
Transfection
Transfections of siRNA or plasmid were performed using
Lipofectamine 2000 CD reagent (Life Technologies). Silencing
RNA transfections [performed as described previously (Pidoux
et al., 2014)] were performed with AKAP18 stealth siRNA
(HSS145157) and control (Life Technologies). Mammalian
expression vector (2 μg) was incubated with the cells for 48 h at
37◦C. TEpacVV clone was described previously (Klarenbeek et al.,
2011). The construct was veriﬁed by sequencing. Transfection
eﬃciency was determined to be >45%.
Optical Biosensor Recordings
Optical recording with biosensor was performed as previously
described (Polito et al., 2013). Wide-ﬁeld images were obtained
with Olympus BX50WI upright microscope with a 20× 0.5 NA
or a 40× 0.8 NA water-immersion objective and an ORCA-
AG camera (Hamamatsu). Images were acquired with iVision
(Biovision). The excitation and dichroic ﬁlters were D436/20 and
455dcxt. Signals were acquired by alternating the emission ﬁlters,
HQ480/40 for CFP and D535/40 for YFP, with a ﬁlter wheel
(Sutter Instruments). Image acquisition was triggered manually,
except for kinetics measurement where images were acquired
automatically within 3–5 s intervals. Pseudocolor images display
the ratio value coded in hue and the ﬂuorescence intensity coded
in intensity. A calibration square indicates the intensity values
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from left to right and the ratio values from bottom to top. The
size of the square indicates the scale of the image in microns.
RNA Extraction
Total RNA was extracted from primary trophoblast cells after 24
or 72 h of culture by using the Trizol reagent (Life Technologies).
The yield of extracted RNA was determined by measuring optical
density at 260 nm. The purity and quality of extracted RNA were
subsequently assessed by electrophoresis on 1% agarose gel with
ethidium bromide staining. Only high-integrity RNA samples
were used for PCR analysis.
RT-Polymerase Chain Reaction
Reverse transcription-polymerase chain reaction (RT-PCR) was
performed with the TaqMan R©Array Human Phosphodiesterase
(4414075, Applied Biosystem) and Human PrimePCR
Phosphatases (H384, Biorad) or primers ordered from Santa-
Cruz Biotechnology according to the manufacturers’ protocols
for analysis of PDEs, PPs, and AKAPs, respectively. GAPDH or
ACTBmRNA and 18S RNA levels were used as endogenous RNA
controls and were tested to remain constant during trophoblast
fusion. Relative gene expression (CT) was calculated by
subtracting the signal threshold cycle (CT) of 18S or GAPDH
from the CT value of each studied gene. Subsequently, CT
values were calculated by subtracting 18S or GAPDH CT
(set as calibrator) from the CT of each individual gene and
transformed and presented as 2−CT in order to obtain the
relative gene expression (fold) of genes of interest.
Phosphodiesterase Activity
LANCE Ultra cAMP assay was modiﬁed and adapted to total cell
lysate to measure the cAMP-PDE activity. The europium chelate
(Eu)-cAMP tracer molecule is captured by an ULight-labeled
anti-cAMP monoclonal antibody (mAb), which brings donor
and acceptor dye molecules into close proximity. Following
irradiation of the samples at 340 nm, the excited energy of the Eu
chelate donor is transferred by FRET to the ULight acceptor dye.
Thus ULight molecules emit a signal detectable at 665 nm in TR-
FRET mode. Residual energy from the Eu chelate produce light
at 615 nm and remains constant. In the absence of free cAMP,
maximal TR-FRET signal is achieved. Free cAMP produced
by stimulated cells competes with the Eu-cAMP tracer for the
binding to the ULight mAb, causing a decrease in TR-FRET signal
proportional to the concentration of cAMP produced. LANCE
Ultra cAMP provides an assay with S/B ratio of 44.6 and an IC50
of approximately 1 nM.
Proteins from trophoblast cell lysate (20 μg) were incubated
in presence of 6 nM cAMP with PDE antagonists or DMSO as
vehicle, for 90 min at 24◦C and under shaking. Subsequently
(Eu)-cAMP tracer molecule and ULight-labeled anti-cAMP
antibody were added to the solution prior to analysis. Cyclic AMP
hydrolysis was below 20%. Histograms represented the proﬁle of
PDE activity in trophoblasts.
Statistical Analysis
The GraphPad Prism 6 software package was used for statistical
analysis. Diﬀerences between groups were evaluated with
ANOVA. Post hoc analysis (Tukey) was used for individual
comparisons and to obtain p-values shown in the ﬁgure legends.
The sample size and signiﬁcance level is shown in the ﬁgure
legends for each graph. All data are presented as means ± SEM.
P < 0.05 was considered statistically signiﬁcant.
Results
Protein Kinase A Triggers Human Trophoblasts
Fusion
Human placental trophoblasts express RIα, RIIα regulatory
subunits and the Cα, Cβ catalytic subunits as evident from
immunoblots (Figures 3A,B) which support earlier reports
(Keryer et al., 1998a,b). RIα is in the cytosol and decreases
signiﬁcantly during the cell fusion process and diﬀerentiation to
STs while RIIα remains constant and relocates from the cytosol to
the Golgi apparatus and to the plasma membrane (Keryer et al.,
1998a,b). Interestingly the loss of PKA RIα protein expression
during cell fusion process was not associated with a decrease in
mRNA level (data not shown), but is probably due to protein
destabilization. Indeed, hCG-mediated cAMP increase during
syncytialization dissociates and activates PKA holoenzyme and
the free RIα and C subunits have been shown in other cell types
to be more rapidly degraded to prevent overshoot of catalytic
activity in response to signal transduction by cAMP (Tasken
et al., 1993). A chemical proteomics approach where we did
cAMP aﬃnity chromatography followed by mass spectrometry
analysis allowed us to identify PKA RIα and RIIα in human
CT and STs (Figure 3B), which supported previous reports
and our observations by immunoblot analysis. Furthermore, we
also observed expression of PKA RIβ isoform in CT and ST at
a constant level during cell fusion (Figure 3A; Pidoux et al.,
2014).
In vitro, the addition of cAMP analogs or hCG promote CT
fusion to ST, whereas PKA inhibitors (H89) or a cell permeable
version of protein kinase inhibitor (PKI) impair cell fusion
(Figure 3C; Keryer et al., 1998b; Pidoux et al., 2014). It has
been proposed that type I PKA is the major PKA holoenzyme
that control the cell fusion process and in a less extend type II
PKA (Keryer et al., 1998a). Moreover the redistribution of type
II PKA during cell fusion is suggested to control the transport of
vesicles from trans-Golgi network leading to hormone secretion
as well as in the reorganization of the subcortical cytoskeleton
occurring during the plasmalemma membrane fusion between
CT (Keryer et al., 1998a). Interestingly, transient overexpression
of the PKA catalytic subunit led to an increase fusion of the
trophoblast-derived choriocarcinoma cell line BeWo cells (Knerr
et al., 2005).
A Kinase Anchoring Proteins Control Placental
Functions
A kinase anchoring proteins are structurally diverse family
of functionally related proteins that include more than 50
members (including space variants) (Pidoux and Tasken, 2010).
They are deﬁned on the basis of their ability to bind to
PKA and co-precipitate catalytic activity. This binding ensures
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FIGURE 3 | Characterization of PKA in human trophoblasts. (A) Immunoblot analysis of RIα, RIβ, RIIα, and Cα/β in lysates of human primary trophoblasts at 24
and 72 h of culture. CT, ST (formed after 72 h of culture). (B) PKA R subunits identified by cAMP pulldown in trophoblasts. Proteins from CTs and STs were purified
by cAMP affinity chromatography and identified by nanoLC-LTQ Orbitrap Mass Spectrometry analysis of tryptic digests of bands excised from SDS-PAGE. (C) Effect
of 8-Br-cAMP (100 μM), hCG (1 μM), scrambled PKI or PKI peptide (10 μM each) and H89 (3 μM) on trophoblast fusion at 72 h of culture. Cells were
immunostained for desmoplakin (magenta) and nuclei were counterstained with DAPI (left). Syncytia (ST) boundaries are indicated by dashed lines. Effect of
8-Br-cAMP, hCG in combination with PKI peptide or H89 on cell fusion represented as fusion indices histograms (upper right). Results are expressed as the
mean ± SEM of n = 3 independent experiments (∗∗∗p < 0.001). Scale bar: 30 μm.
speciﬁc subcellular compartmentalization of the enzyme thereby
providing spatial and temporal regulation of the PKA-signaling
events. All AKAPs contain a PKA regulatory-binding domain
that consists of an amphipatic helix of about 14–18 residues
(Carr et al., 1991). Moreover, all AKAPs present a unique
targeting domain directing the PKA–AKAP complex to deﬁned
subcellular structures, membranes, or organelles (Figure 2). In
addition to these two domains, several AKAPs are also able to
form multivalent signal transduction complexes by interaction
with phosphoprotein phosphatases (PPs), kinases, PDEs and
other proteins involved in signal transduction (Coghlan et al.,
1995; Schillace and Scott, 1999; Feliciello et al., 2001; Tasken
et al., 2001; Scott and Pawson, 2009). This scaﬀolding property
of AKAPs functions to coordinate cell-signaling events in
space and time and enhance cross talk between signaling
pathways. Type II PKA is typically particulate and conﬁned
to subcellular structures and compartments anchored by cell-
and tissue-speciﬁc AKAPs (Colledge and Scott, 1999; Dodge
and Scott, 2000; Diviani and Scott, 2001). However, several
RI-speciﬁc AKAPs have also been characterized (i.e., SKIP,
smAKAP), although the type I PKA, which is classically
known to be biochemically soluble, has been assumed to
be mainly cytoplasmic (Means et al., 2011; Burgers et al.,
2012). In addition, dual-speciﬁc AKAPs (D-AKAPs) are capable
of anchoring both types of R subunits (Huang et al.,
1997a,b).
Several AKAPs have been identiﬁed in placenta or placental
trophoblast cell lines, for instance the AKAP PAP7 is highly
expressed in placenta (Li et al., 2001; Liu et al., 2003; Weedon-
Fekjær and Taskén, 2012). A number of other AKAPs are
expressed in varying amounts in placenta such as AKAP18γ,
AKAP350, and AKAP-Lbc 10 kb transcript (Lin et al., 1998;
Trotter et al., 1999).
In search for AKAPs in primary CTs, proteins from subcellular
fractionation or eluates from pull-down of cAMP-binding
proteins using 8-AHA-cAMP-agarose beads were separated by
SDS-PAGE, blotted to nitrocellulose membranes which were
overlaid with radiolabelled RII in the absence or presence of Ht31
anchoring disruptor peptide (Figure 4A). Several bands with
molecular masses in range of ∼160 and ∼15 kDA were detected
in cytosol, membrane, nucleus, and cytoskeleton fraction by
RII-overlay and competed by Ht31 peptide (Figure 4A). In
the same manner, bands with similar molecular masses were
detected by RII-overlay following pull-down of cAMP-binding
proteins (Figure 4A). Our original observations are in agreement
with previous studies looking at mRNA expression of AKAPs
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FIGURE 4 | Characterization of AKAPs in human CTs. (A) Proteins purified by sub-cellular fractionation (left) or by cAMP affinity chromatography (right) from
cytrophoblasts were subjected to a solid phase binding assay using 32P-radiolabeled RII (RII-overlay) as a probe in the absence or presence of the Ht31 anchoring
disruptor peptide (500 nM). Red arrowheads indicate putative AKAPs expressed in CTs. (B) Total RNA was purified from CTs (n = 3 cultures each) and subjected to
RT-PCR with specific AKAP primers (identified in Table 1). Histograms represent mRNA expression of AKAPs in CTs normalized to beta-actin mRNA expression.
(C) Cx43 gap junction communication is controlled by PKA anchoring through ezrin (Pidoux et al., 2014). Schematic depiction of a resting state gap junction in
primary human trophoblast with Cx43 and a compartmentalized pool of PKA anchored to ezrin thus bound to Cx43 (left). Elevated intracellular cAMP levels lead to
activation of PKA and subsequent spatiotemporally controlled phosphorylation of Cx43, which promotes the communication through gap junctions. This
communication triggers trophoblast cell fusion. C, catalytic subunit of PKA; P for phosphorylation; pink dots, molecules of cAMP. (D) BeWo cells were transfected
with AKAP18 siRNA (Invitrogen, Cat. # 1299001) or scrambled control, cultured for 48 h, stimulated for fusion with FSK (15 μM) for 24 h and subjected to
immunoblot analysis with the indicated antibodies (upper left). Cells with AKAP18 knockdown or controls were stained for desmoplakin (magenta) and nuclei (DAPI).
Syncytia (ST) boundaries are indicated by dashed lines. Scale bar: 30 μm. (Lower left) The effects of AKAP18 siRNA, scrambled control on fusion were assessed
after 24 h treatment with FSK (15 μM) and summarized in histograms (right). Results are expressed as the mean ± SEM of n = 3 independent experiments
(∗∗∗p < 0.001). Scale bar: 30 μm.
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and suggesting existence of several AKAPs in human primary
CTs. To identify AKAPs involved in the cell fusion process, we
isolated cAMP-signaling complexes from cultures CTs and ST,
either by pull down of cAMP-binding proteins or by FLAG-
aﬃnity chromatography after incubation with puriﬁed FLAG-
tagged regulatory RI and RII subunits, and we subjected bands
excised and eluted from SDS-PAGE to tryptic digestion and
mass spectrometry analysis. By this approach we identiﬁed 11
AKAPs, which are summarized in Table 1. An RT-PCR screening
strategy was applied to characterize expression of AKAP mRNAs
in CTs (Figure 4B). We found that these cells expressed
AKAP mRNAs with various levels that supports our mass
spectrometry analysis. A screen by siRNA-mediated knockdown
of various identiﬁed-AKAPs allowed us to characterize the
involvement of ﬁve AKAPs (D-AKAP1, AKAP18, AKAP450,
Ezrin, and myomegalin) in the regulation of cell fusion (Table 1;
Pidoux et al., 2014). This suggests speciﬁc roles for pools of
AKAP-anchored type I and/or type II PKA in trophoblast
fusion.
We recently demonstrated that trophoblast fusion is regulated
by ezrin, a known AKAP, which binds to connexin-43
and delivers PKA in the vicinity gap junctions. We found
that disruption of the ezrin-Cx43 interaction abolished PKA-
dependent phosphorylation of Cx43 as well as gap junction
communication and subsequently hCG-induced cell fusion in
human primary trophoblasts (Figure 4C; Pidoux et al., 2014).
This appears to be a general mechanism for gating of Cx43 gap
junctions and a dominant mechanism in controlling CT fusion,
although not the only mechanism.
Looking at other AKAPs that could be involved in hCG
action and cell fusion, AKAP79, AKAP95, and AKAP250
(gravin) were also detected in the trophoblast cell line BeWo
(Delidaki et al., 2011). In the same study, the authors
demonstrated cross talk between the cAMP/PKA and MAPK
pathways involved in secretion of hCG, which acts as an
auto-paracrine loop to induce trophoblasts fusion. The authors
found that this cross talk was dependent on PKA and PKA–
AKAP interaction as a speciﬁc PKA inhibitor (myr-PKI)
and a PKA anchoring disruptor peptide (Ht31) inhibited
the forskolin (FSK)-induced MAPK stimulation (Delidaki
et al., 2011). Based on our original observations, siRNA-
mediated knockdown of AKAP18 in BeWo cells reduced
all isoforms of AKAP18 expression after normalization to
GAPDH levels compared with cells transfected with scrambled
TABLE 1 | A-kinase-anchoring proteins (AKAPs) identified in trophoblasts.
AKAP (gene
nomenclature
committee name)
Method of identification Subcellular localization Properties/function CT/ST Cell-fusion
D-AKAP1 (AKAP1) RII affinity chromatography Outer mitochondrial membrane
Endoplasmic reticulum Nuclear
envelope
Dual-specific AKAP (D-AKAPs)
Binds lamin, PP1 and PDE7A
Multiple splice variants
CT Decrease – T
AKAP-KL (AKAP2) RII affinity chromatography Actin cytoskeleton Apical
membrane
Multiple splice variants CT/ST No effect – T
AKAP18α, β, γ, δ
(AKAP7)
cAMP chromatography Basolateral (α) Apical (β) Plasma
membrane (γ) Cytoplasm (γ)
Secretory vesicles (δ)
Targeted to plasma membrane
Modulation of Na+ Associate to
L-type channels (α)
CT Decrease – BW
AKAP95 (AKAP8) RII affinity chromatography Nuclear matrix Chromosome condensation Binds
Eg7, condensin and PDE7A
CT/ST No effect – T
AKAP450 (AKAP9) RII affinity chromatography Centrosome Golgi Binds PDE4D3, PP1, PP2A PKN
and PKCε Targets PKA and PP1 to
NMDA-R Multiple splice variants
CT/ST Decrease – T
D-AKAP2 (AKAP10) cAMP chromatography Vesicles Peroxisomes
Centrosome
D-AKAPs Binds PP1, PP2A CT No effect – T
Gravin (AKAP12) RII affinity chromatography Actin cytoskeleton Cytoplasm Binds PKC and β-AR CT ? – T
AKAP-Lbc (AKAP13) RII affinity chromatography Cytoplasm Binds Rho-GEF Couples Gα12 to
Rho
CT/ST ? – T
Ezrin RI/II and cAMP
chromatography
Actin cytoskeleton Plasma
membrane
D-AKAPs Binds Cx43 Linked to
CFTR via EBP50 RISR domain
CT/ST Decrease – T
Myomegalin RII affinity chromatography Cytoskeleton Centrosome
Cytoplasm
Binds PDE4D CT Decrease – T
OPA1 RI affinity chromatography Inner mitochondrial membrane
Mitochondrial intermembrane
Lipid droplets
D-AKAPs CT ? –T
Proteins from cytotrophoblasts and syncytiotrophoblast were purified by cAMP or RI-flag and RII-flag affinity chromatography and identified by nanoLC-LTQ Orbitrap
Mass Spectrometry analysis of tryptic digests of bands excised from SDS-PAGE. For each AKAP, the subcellular localization, the properties described in literature and
the cellular origin of the identification (CT for cytotrophoblast and/or ST for syncytiotrophoblast) were specified. The effect of tested siRNA mediated knockdown on
trophoblast fusion was presented from in vitro experiments using primary culture of human trophoblasts (T) or BeWo cells (BW). Silencing of AKAPs not tested on cell
fusion was indicated by “?”.
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siRNA (Figure 4D). SiRNA mediated depletion of AKAP18
decreased BeWo cell fusion after treatment with FSK (a
potent cAMP activator) by approximately 60% (p < 0.001)
compared to scrambled control transfected cells. It is known that
AKAP18 isoforms are involved in the regulation of intracellular
calcium ﬂuxes. AKAP18α/β is associated with the plasma
membrane and is necessary for PKA-dependent phosphorylation
of the L-type Ca2+ channel under β-adrenergic stimulation
in cardiomyocytes. This phosphorylation by PKA increases
the opening probability and conductance of this channel
(Fraser et al., 1998). AKAP18γ/δ located to the sarcoplasmic
reticulum membrane facilitates adrenergic regulation of calcium
reabsorption from cytosol by regulating phospholamban that
controls the sarcoplasmic reticulum calcium ATPase Serca2
(Lygren et al., 2007). It is noteworthy that trophoblastic
syncytialization requires extracellular calcium (Dimitrov et al.,
1993; Rote, 2005). Furthermore, calcium entry through L-type
Ca2+ channel controls hCG released, which could indirectly
triggers cell fusion in an auto-paracrine manner (Meuris et al.,
1994). However, more experiments are needed to fully decipher
the putative regulation of a PKA–AKAP18 complex in cAMP
signaling-induced calcium homeostasis in BeWo cell fusion.
Another AKAP, AKAP-121 co-immunoprecipitates with PKA
and protein tyrosine phosphatase (PTP) D1 in ST mitochondrial
membrane that could be involved in progesterone synthesis
(Gomez-Concha et al., 2011).
Cyclic AMP PDE Control Human Trophoblasts
Fusion
Cyclic AMP-PDE contribute to the regulation of local cAMP
gradients by speciﬁcally hydrolyzing the phosphodiester bond of
cyclic nucleotides thereby controlling the cAMP cellular level,
mediating its return to the basal state concomitantly forming
intracellular AMP (Figure 2). The termination of cAMP signaling
is conferred by a large enzyme superfamily that includes over
40 diﬀerent PDE isoforms (Baillie et al., 2005; Lugnier, 2006).
In mammals, 3 of the 11 PDE families selectively hydrolyze
cAMP (PDEs 4, 7, and 8), three families are selective for cGMP
(PDEs 5, 6, and 9), and ﬁve families hydrolyze both cyclic
nucleotides with varying eﬃciencies (PDEs 1, 2, 3, 10, and
11) (Lugnier, 2006; Conti et al., 2007). An explanation of the
complexity of PDEs and the existence of numerous splicing
variants is that the divergent domains specify protein–protein
interactions. These interactions engender a catalytic domain with
new regulatory properties and integrate the function of the
holoenzymes in macromolecular complexes strategically located
within the cell. Although PKA may interact directly with some
PDEs, most interactions with kinases and phosphatases are
mediated by AKAPs and participate to intracellular signaling
compartmentation (Figure 2; Dell’Acqua and Scott, 1997).
The presence of cAMP-PDE activity in human placenta was
ﬁrst reported (Ferre et al., 1975). Since then PDE3 and PDE4 were
characterized in cytosolic fraction of human placenta biopsies
(Xiong et al., 1990). To further examine the role of PDEs in
human primary trophoblast, we performed live-cell imaging and
ﬂuorescence resonance energy transfer using TEpacVV biosensor
(Figure 5A) (Klarenbeek et al., 2011). Trophoblasts were
transfected with a plasmid directing the expression of TEpacVV
biosensor to visualize the dynamic of cAMP accumulation and
PDE activity under hCG stimulation (Figure 5A). Activation of
the LH/CG-R with a supraphysiological concentration of hCG
(1 μM) increased the F480/F535 emission ratio (Figure 5A).
The maximal response was obtained by the addition of the
AC activator FSK (15 μM) in combination with IBMX (pan-
PDE inhibitor; 200 μM). These original ﬁndings indicate that
hCG promotes cAMP synthesis and suggest that PDEs could
regulate the cAMP signaling in human CTs. Thus an RT-
qPCR screening strategy was applied to characterize PDE genes
expression in CTs and ST (Figure 5B). Interestingly, the fusion
process did not induce changes in the PDE gene expression
proﬁle (unpublished data). However, we found that trophoblasts
expressed mRNA of PDE7A, PDE8A, and PDE10A isoforms
at high levels and PDE4A mRNA to a lesser extent whereas
trophoblasts displayed low levels of expression of PDE1A,
PDE1C, PDE2A, PDE4B, and PDE4D mRNA. Interestingly, no
mRNA expression was observed for PDE1B, PDE3A, PDE3B,
and PDE4C isoforms in human trophoblasts. It is noteworthy
that PDE3 activity identiﬁed by Xiong et al. (1990) was assessed
on human placental biopsies comprising other cell types than
trophoblasts that may express PDE3. To support these data, we
also examined cAMP-PDE activity in human CT cell extracts
by using a TR-FRET strategy (Figure 5C). As evident from the
data, IBMX signiﬁcantly reduced the PDE activity in trophoblast
cell lysates compared to vehicle. Furthermore, using speciﬁc
antagonists we found mainly PDE4 and PDE7 activity and to
a less extent PDE2 activity. Interestingly, no PDE8 and PDE10
activity were detected in CT lysate, whereas mRNA of these two
PDE isoforms were characterized. Moreover, no PDE3 activity
was found, which is in agreement with our RT-qPCR analysis
and the absence of PDE3 mRNA. In order to establish the
temporal eﬀect of PDE antagonists on cell fusion of primary
trophoblasts from human placenta, cells were cultured for 24 h in
the presence of hCG to induce cell fusion with or without IBMX,
Cilostamide (PDE3 antagonist), and Rolipram (PDE4 antagonist)
(Figure 5D). As evident from immunostaining and activity data,
the combination of hCG and pan-PDE or PDE4 antagonists
potentiated human trophoblast fusion in the same manner
compared to cells treated with hCG alone. PDE3 antagonists
displayed no eﬀects on cell fusion, which is in agreement with
the absence of PDE3 mRNA and activity in human CTs. We
demonstrate for the ﬁrst time that various cAMP-PDEs are
expressed in human CT and PDE4 isoform regulates the CT
cell fusion. However, more experiments need to be performed
to identify the speciﬁc PDE4 isoforms that regulates the human
trophoblast fusion and in which subcellular compartment this
occurs.
Serine/Threonine PPs Expression Profile in the
Primary Human Trophoblasts
To our knowledge, there are no reported studies of PPs
in trophoblasts and their putative role in the regulation
of cell fusion. An RT-qPCR screening strategy was applied
to characterize expression of PP mRNAs in CTs and ST
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FIGURE 5 | Characterization of cAMP-PDEs in human CTs. (A) CTs purified from human placenta were transfected with a DNA construct directing the
expression of the TEpacVV biosensor and imaged with wide field microscopy. Images show the fluorescence at 535 nm (upper left, in gray scale) and the ratio (in
pseudocolor; lower row) indicating a ratiometric change of TEpacVV, reporting the binding of cAMP at the times indicated by arrows on the graph (upper right panel).
The trace on the graph indicates the F480/F535 emission ratio measurement on region indicated in red on the gray scale image. Human CG (1 μM) induced a robust
ratio increase in CTs. FSK + IBMX incubation were used to induced the maximal response. Data are representative of three separate experiments (B) cAMP-PDE
mRNA expression profile in CTs. Total RNA was purified from CTs (n = 5 cultures) and subjected to RT-qPCR, using Human PDE TaqMan Gene Expression Assays
chip (Applied Biosystems). Histograms represent mRNA expression of cAMP-PDEs in trophoblast normalized to 18S rRNA expression. (C) Cyclic AMP-PDE activity
in human CTs. LANCE Ultra cAMP assay (Perkin Elmer) was adapted to quantify PDE activity in total CT lysates. Trophoblast cell lysates (20 μg) were incubated in
presence of 6 nM cAMP with or without PDE antagonists, subsequently (Eu)-cAMP tracer and ULight-labeled anti-cAMP antibody were added to the solution prior to
analysis. Histograms represented the profile of PDE activity in trophoblasts. (D) Effect of PDE inhibitor on CT fusion. Cytrophoblasts were stimulated with hCG (1 μM)
and treated with pan-PDE (IBMX, 200 μM), PDE4 (Rolipram, 4 μM) or PDE3 (Cilostamide, 100 nM) antagonists. Cells were stained for desmoplakin (magenta) and
nuclei (DAPI, left), Syncytia (ST) boundaries are indicated by dashed lines and fusion indices were measured (right histograms). Results are expressed as the
mean ± SEM of indicated independent experiments (n.s., non significant, ∗p < 0.05, ∗∗∗p < 0.001). Scale bar: 30 μm.
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FIGURE 6 | Characterization of PPs in human trophoblasts.Messenger RNA expression profile of serine/threonine protein phosphatases (PPs) in trophoblasts.
Total RNA was purified from CTs and ST (n = 5 cultures each), pooled and subjected to RT-qPCR, using Human Phosphatase Collection Panel chip (Prime PCR,
Biorad). (A) Table shows mean ± SEM of CT and associated-relative quantification (RQ). (B) Histograms represent mRNA expression of PPPs in trophoblast
normalized to GAPDH mRNA expression.
(Figure 6). We found that trophoblasts expressed mRNA of
PP1, PP2A catalytic subunits, and PP1 regulatory subunit 15B
and 3B isoforms and PP2A regulatory subunit alpha isoform
(Figure 6), whereas expression of calcineurin (PP2B) mRNA
was weaker. Interestingly, the fusion process did not induce
modiﬁcations in PP genes expression proﬁles (unpublished
data). By immunoblotting we characterized expression of
PP1-Cα, PP2A-Cα/β, and Calcineurin A subunits in primary
human trophoblasts (data not shown). Protein phospho- and
dephosphorylation, controlled by kinases and phosphatases,
respectively, aﬀect many cellular processes and their regulations
must be speciﬁc to act on a deﬁned subset of cellular targets to
ensure signal ﬁdelity. More experiments need to be done here
to identify subcellular targets of PPs and may characterize in
detail their functions in the regulation of human trophoblasts
fusion.
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Discussion
Trophoblast fusion and ST formation is a complex biological
process essential for the maintenance of pregnancy and for fetal
growth. For more than two decades, it have been recognized
that the cAMP/PKA signaling pathway is the major signaling
pathway involved in this process, which modulates the expression
of proteins that trigger human trophoblast fusion (Gerbaud
and Pidoux, 2015). However, cAMP-induced trophoblast fusion
remains a ﬁeld where a number of molecular details remain to
be elucidated. To this end, the characterization of components
of the cAMP signaling pathway (PDEs, PPs, and AKAPs) as
reported here and may help understand how cAMP signaling
as propagated intracellularly to regulate this complex biological
process.
In an autocrine–paracrine loop, hCG binds to LH/CG-
R at the membrane of human trophoblasts and induces
intracellular cAMP production (Shi et al., 1993; Keryer et al.,
1998b; Pidoux et al., 2007a,b, 2014). Subsequently, cell fusion
is triggered by activation of PKA that phosphorylates the
CREB transcription factor (cAMP Response Element-Binding
Protein), which associates with CBP (CREB-binding protein)
and P300 to increase speciﬁc gene expression of fusogenic
proteins (i.e., hCG, GCM1, Cx43, and syncytins; Knerr
et al., 2005; Chen et al., 2008; Chen and Cheong, 2011; Ul
Hussain, 2014). Moreover, induction of cAMP/PKA signaling
promotes association between the transcription factors GCM1
and CBP, thereby enhancing the transcription of fusogenic
genes such as those encoding Cx43 and syncytins (Chen and
Cheong, 2011; Dunk et al., 2012; Gerbaud and Pidoux, 2015).
Despite all of these characterized events, speciﬁc roles of
individual PKA isoforms in the regulation of the trophoblast
fusion process remains to be elucidated. Furthermore, precise
spatial and temporal activation of PKA inside the cell is
accomplished by sequestering PKA in speciﬁc locations through
interaction with AKAPs and by generation of localized pools of
cAMP.
Protein kinase A is considered as the major eﬀector of the
cAMP-signaling pathway. However, other intracellular eﬀectors
for this signaling exist such as exchange proteins activated
by cAMP (Epac) and the cyclic nucleotide-gated ion channels
(CNG) (Figure 2). CNGs are heterotetrameric complexes that
are composed by diﬀerent types of subunits. CNG channels are
non-selective cation channels allowing passage of alkali ions
as well as divalent cations (i.e., Ca2+) (Kaupp and Seifert,
2002). The opening of CNG channels is under dependence
of cyclic nucleotide binding (either cAMP and/or cGMP). To
our knowledge, the role and full characterization of CNG
channels in trophoblasts and during cell-fusion has not been
assessed. Epac have been identiﬁed less than two decades
ago and characterized as an important eﬀector of the cAMP
signaling cascade that act diﬀerently that PKA (de Rooij et al.,
1998; Kawasaki et al., 1998). Epac signaling is involved in cell
diﬀerentiation, secretion of vesicles, cell adhesion, and cell–cell
adhesion (Bos, 2006). The Epac family comprises Epac1 and
Epac2. Epac1 is ubiquitously expressed while Epac2 has been
originally identiﬁed in brain and adrenal glands (Kawasaki et al.,
1998). Epac binds cAMP on a CNB domain (cyclic nucleotide-
binding) and subsequently function as a guanine nucleotide
exchange factors (GEFs) for Rap1 and Rap2, which belongs to
Ras family of small G protein. In the guanosine diphosphate
(GDP)-bound state Epac is inactive and becomes active once
GDP is exchanged for guanosine triphosphate (GTP). GEFs
induce the transfer of GDP for GTP and thereby the activation
of the small G protein, whereas GTPase-activating proteins
(GAPs) hydrolyze GTP (for review, Gloerich and Bos, 2010).
Recent studies undertook to characterize the role of Epac in
trophoblast cell fusion. Yoshie et al. (2010) found the expression
of Epac1 and Epac2 in CT and STs. In the same report, the
authors showed that Epac activation promotes BeWo cell fusion.
However, the molecular mechanisms underlying this process
were not clear. In another recent report, it has been shown
that an Epac/CaMKI signaling cascade works in synergy with
PKA signaling to trigger BeWo cell fusion. This cascade activates
GCM1 transcription factor, which enhances the transcription of
fusogenic genes (Chang et al., 2011). More studies are needed to
fully elucidate the molecular mechanisms underlying trophoblast
cell fusion and ST regeneration, and thus the pathophysiology
of human placental development. Any alteration of syncytial
formation and regeneration during pregnancy will aﬀect fetal
growth and the outcome of the pregnancy. Anomalies of villous
trophoblast diﬀerentiation and cell fusion can lead to severe
placental abnormalities that could lead to intrauterine growth
restriction (IUGR) and preeclampsia (Huppertz and Kingdom,
2004). A better understanding in the cAMP signaling pathway
and its regulation in space and time that induce cell fusion
could lead to the development of therapeutic tools that may
counteract pathologies of the pregnancy with a defect in syncytial
formation.
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